Scarica l'app Stockscreener
0.2465
3.37%
-0.0086
Dopo l'orario di chiusura:
.25
0.0035
+1.42%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché ADIL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.2551
Aprire:
$0.255
Volume 24 ore:
403.21K
Relative Volume:
0.87
Capitalizzazione di mercato:
$6.57M
Reddito:
-
Utile/perdita netta:
$-6.07M
Rapporto P/E:
-0.0426
EPS:
-5.78
Flusso di cassa netto:
$-7.34M
1 W Prestazione:
+7.83%
1M Prestazione:
-20.12%
6M Prestazione:
-24.59%
1 anno Prestazione:
-77.15%
Intervallo 1D:
$0.2411
$0.26
Intervallo di 1 settimana:
$0.2165
$0.2699
Portata 52W:
$0.2165
$1.30
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Nome
Adial Pharmaceuticals Inc
Settore
Industria
Telefono
434-422-9800
Indirizzo
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Confronta ADIL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
0.2465 | 6.80M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2018-10-30 | Iniziato | Maxim Group | Buy |
| 2018-10-11 | Iniziato | Dawson James | Buy |
Adial Pharmaceuticals Inc Borsa (ADIL) Ultime notizie
Adial Pharmaceuticals announces immediate resignation of board director - TipRanks
Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr. - Investing.com Australia
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Decreases By 31.2% - Defense World
AXIM Biotechnologies (OTCMKTS:AXIM) versus Adial Pharmaceuticals (NASDAQ:ADIL) Financial Comparison - Defense World
Can Adial Pharmaceuticals Inc. stock continue upward trend - Улправда
Will Adial Pharmaceuticals Inc. stock split again soon2025 Macro Impact & Low Volatility Stock Recommendations - Улправда
Published on: 2025-12-20 18:07:08 - Улправда
Is Adial Pharmaceuticals Inc. stock cheap at current valuationMarket Activity Report & Technical Confirmation Alerts - Улправда
Published on: 2025-12-19 03:23:09 - Улправда
Will Adial Pharmaceuticals Inc. stock deliver shareholder valueStop Loss & Reliable Volume Spike Alerts - Улправда
[EFFECT] ADIAL PHARMACEUTICALS, INC. SEC Filing - Stock Titan
Adial Pharmaceuticals Earnings Notes - Trefis
Volume Recap: Why Adial Pharmaceuticals Inc stock could be next big winner2025 Momentum Check & Consistent Return Strategy Ideas - moha.gov.vn
Litchfield Hills Research Weighs in on ADIL FY2025 Earnings - Defense World
Adial Pharmaceuticals Secures $2.86M Through Warrant Agreement - MSN
Adial Pharmaceuticals, Inc. (ADIL) AI-Powered Stock Analysis - Meyka
How Adial Pharmaceuticals Inc. stock benefits from strong dollarMarket Performance Report & Weekly Return Optimization Plans - Newser
Can Adial Pharmaceuticals Inc. stock attract ESG capital inflowsPortfolio Return Summary & Low Risk Investment Opportunities - Newser
Whale Trades: Can Adial Pharmaceuticals Inc. stock continue upward trendPortfolio Update Summary & Low Risk Growth Stock Ideas - moha.gov.vn
Are Smart Investors Making the Right Decision? Adial Pharmaceuticals Inc (ADIL) - Setenews
Adial Pharmaceuticals raises $2.86 million through warrant exercise By Investing.com - Investing.com Nigeria
Adial Pharmaceuticals (ADIL) Announces Warrant Inducement Agreem - GuruFocus
Adial Pharmaceuticals raises $2.86 million through warrant exercise - Investing.com
Adial Pharmaceuticals Enters Warrant Inducement Agreement for $2.86 Million Capital Raise - Quiver Quantitative
Adial Pharmaceuticals (NASDAQ: ADIL) enters $2.86M inducement at $0.31 exercise price - Stock Titan
Is Adial Pharmaceuticals Inc a good long term investmentMoving Average Crossovers & Learn to Pick Stocks in Under 10 Minutes - earlytimes.in
Why Adial Pharmaceuticals Inc. stock could rally in 20252025 Year in Review & Expert Verified Movement Alerts - newser.com
Will Adial Pharmaceuticals Inc. stock deliver strong dividend growthJuly 2025 Gainers & Free Reliable Trade Execution Plans - newser.com
Why Adial Pharmaceuticals Inc. stock could benefit from AI revolutionProfit Target & Safe Capital Growth Plans - newser.com
What high frequency data says about Adial Pharmaceuticals Inc.Quarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
Detecting price anomalies in Adial Pharmaceuticals Inc. with AIJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Is this a good reentry point in Adial Pharmaceuticals Inc.July 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - MarketScreener
Will Adial Pharmaceuticals Inc. stock benefit from infrastructure spendingJuly 2025 Drop Watch & Verified Technical Trade Signals - newser.com
Forecasting Adial Pharmaceuticals Inc. price range with options data2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
Can Adial Pharmaceuticals Inc. stock withstand economic slowdownJuly 2025 Selloffs & Short-Term High Return Strategies - newser.com
Will Adial Pharmaceuticals Inc. stock continue upward momentumStock Surge & Reliable Price Breakout Signals - newser.com
Adial Pharmaceuticals' Loss Shrinks As Hopes For AD04 Grow - Finimize
Adial Pharmaceuticals Inc Azioni (ADIL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):